Eosinophilic oesophagitis (EoE) is a chronic, immune-mediated disease characterised by eosinophilic inflammation of the oesophagus with peak eosinophilic count > 15 cells per high power field that may lead to remodelling and fibrotic changes and impaired oesophageal function. (1) We aim to characterize the current practices in the diagnosis, management, and follow-up of EoE at Aberdeen Royal Infirmary.

We conducted a retrospective analysis of electronic data records from 2022 to 2024. This involved identifying EoE cases using histology confirmation, clinical presentation, and mode of treatment at Aberdeen Royal Infirmary, Scotland.

In our cohort, we found 162/690 patients had histology biopsies confirmed EoE. Most patient were Male (125/162). The median age group was 30-40 years old. We found that the most common mode of presentation was dysphagia (63%) followed by food bolus (16.3%). The most recognised endoscopic finding was furrows (21.6%).

37.24% received both Proton pump inhibitors and Jorveza (oral Budesonide dispersable tablets). 45.2% achieved histological remission. There were 20 patients who had strictures and 10 of these patients underwent endoscopic ballon dilation. Although 74 patients had clinical follow up, there was no standardisation of management across the board with fast majority of patients had no follow up (88). Therefore, we believe that this data should raise the awareness of the importance of establishing an EoE clinic for standard medical practice and better patient outcomes.

This audit has highlighted the importance of establishing EoE clinic for standardisation of medical practice, prevent future complications and repeat hospitalisations.